Gareev, Ilgiz,
Beylerli, Ozal,
Tamrazov, Rasim,
Ilyasova, Tatiana,
Shumadalova, Alina,
Du, Weijie,
Yang, Baofeng (2023) on microRNA (miRNA)-based therapy.
MiRNAs possess the ability to function as suppressors of tumor growth
BEYLERLI, OZAL,
BEERAKA, NARASIMHA M.,
GAREEV, ILGIZ,
PAVLOV, VALENTIN,
YANG, GUANG,
LIANG, YANCHAO,
ALIEV, GJUMRAKCH (2020) , including rapid proliferative activity and invasion of neighboring tissues. MicroRNAs (
miRNAs) are short
РОЛЬ МИКРОРНК ПРИ ДЕГЕНЕРАЦИИ МЕЖПОЗВОНКОВОГО ДИСКАБЕЙЛЕРЛИ, О. А.,
ГАРЕЕВ, И. Ф.,
В.Н. Павлов,
BEYLERLI, O. A.,
GAREEV, I. F.,
PAVLOV, V. N. (2020) МикроРНК (
miRNA) представляют собой класс небольших некодирующих молекул РНК, которые негативно
mechanism that is responsible for glioma tumorigenesis and progression remains unclear. MicroRNAs (
miRNAs conducted.
MiRNA targets sites are a promising new area of research. In this study, we analyzed
Gilyazova, Irina,
Gimalova, Galiya,
Nizamova, Aigul,
Nizamova, Aigul,
Ishbulatova, Ekaterina,
Pavlov, Valentin,
Khusnutdinova, Elza (2024) , regulatory mechanisms, and therapeutic potential of ncRNAs including microRNA (
miRNA), long ncRNA (lnc
Wu, JN,
Al-Zahrani, A,
Beylerli, O,
Sufianov, R,
Talybov, R,
Meshcheryakova, S,
Sufianova, G,
Gareev, I,
Sufianov, A (2022) on microRNAs (
miRNAs) expression profiling in glioma and highlighted the most frequently dysregulated
miRNAsBeylerli, Ozal,
Shi, Huaizhang,
Begliarzade, Sema,
Shumadalova, Alina,
Ilyasova, Tatiana,
Sufianov, Albert (2024) (ncRNAs), specifically microRNAs (
miRNAs) and long non-coding RNAs (lncRNAs), present promising
Beilerli, A.,
Kudriashov, V.,
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Ilyasova, T.,
Liang, Ya.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) conditions is still the subject of numerous studies. Recent studies point to the involvement of microRNAs (
miRNAsXu, Dongxiao,
Gareev, Ilgiz,
Beylerli, Ozal,
Pavlov, Valentin,
Le, Huang,
Shi, Huaizhang (2024) medical facilities. This study seeks to discern the pivotal microRNAs (
miRNAs) and genes associated